Dohmen unloads its PBM business, Restat, to Catamaran for $409.5 million
Dohmen will focus more closely on services to life sciences companies
Dohmen (Milwaukee), which over the years has gone from a major regional drug wholesaler, to a portfolio of service companies to pharma and payers, is exiting the pharmacy benefit management (PBM) business with the sale to Catamaran. The sale will close in the fourth quarter.
“We’ve decided to exit the pharmacy benefit management business so we can focus exclusively on our life science clients,” said Cynthia LaConte, Dohmen CEO. “Dohmen has a long history of anticipating transformative change and building better business models to meet it, and our industry is facing a significant paradigm shift from volume to value. We think we’re uniquely positioned to help drug, device and personalized medicine companies make this transition.”
In the past two years, Dohmen had added a specialty pharmaceuticals distributor (Centric Health), a medical devices distributor (Reglera) and two medical communications firms, BioSoteria and MedComm Solutions, to its existing businesses, DDN, a logistics services provider and a private investment group. Catamaran, meanwhile, styles itself as the fastest-growing PBM in the US, having been formed from the merger of SXC Health Solutions and Catalyst Health Solutions a year ago. The Lisle, IL, firm boasts 25 million members.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
